Thrombocytopenia can be caused by problems in the bone marrow or the immune system. The bone marrow may not make enough platelets, or the immune may destroy platelets inappropriately. Some of the ...

US-based biotech Rallybio is ending its RLYB212 programme for the prevention of fetal and neonatal alloimmune ...

Recently however, reports of thrombosis and thrombocytopenia following vaccination with the ChAdOx1 nCoV-19 vaccine have emerged. This paper aims to review the available literature and guidelines ...

Considering taking supplements to treat thrombocytopenia? Below is a list of common natural remedies used to treat or reduce the symptoms of thrombocytopenia. Follow the links to read common uses ...

CORPUS CHRISTI, Texas — Local non-profit, TARS Awareness Texas, is asking you to join them at their 3rd annual 5K run and ...

RLYB212 Phase 2 PK Results Did Not Achieve Target Concentrations, Including Minimum Target Concentration Required for Efficacy – ...

Rallybio said it discontinued its RLYB212 program following disappointing results in a phase 2 trial. Pharmacokinetic data demonstrated an inability of the RLYB212 dose regimen to achieve predicted ...

LUND, SWEDEN / ACCESS Newswire / April 8, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicinesDesignation granted for warm autoimmune ...